John Patience, Director, 10% Owner at Accelerate Diagnostics, Inc (AXDX), bought 10,000 shares at $14.96 ($150K) on 2018-11-08, disclosed to the SEC on 2018-11-13.
Open-market purchase of $150k AXDX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| BDSX | BUY | 2022-11-21 | $4.0M | — | Filing → |
| BDSX | BUY | 2022-04-11 | $1000K | — | Filing → |
| BDSX | BUY | 2022-01-04 | $1.4M | — | Filing → |